Prometheus stock
WebDec 9, 2024 · Prometheus Biosciences (NASDAQ:RXDX) stock soared nearly 225% in the past two days and hit $117.73 for the first time since going public in March 2024.Positive Phase-2 trial results for its PRA023 drug, designed to treat ulcerative colitis and Crohn’s disease, supported the rally.. As the next step, Prometheus CEO Mark McKenna said, “We … WebFeb 28, 2024 · The stock of Prometheus Biosciences has tripled since positive mid-stage trial results for its primary candidate for treating UC and CD came out in early December. Since then the company has done ...
Prometheus stock
Did you know?
Web2 days ago · Prometheus Biosciences (NASDAQ: RXDX) stock is rocketing higher on Wednesday after reporting results from its ARTEMIS-UC Phase 2 and APOLLO-CD Phase … WebApr 14, 2024 · Tokyo, Japan, April 14, 2024 (GLOBE NEWSWIRE) -- Yoshitsu Co., Ltd (“Yoshitsu” or the “Company”) (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, as well as sundry products and other products in Japan, today announced that, on April 5, 2024, Prometheus Capital Fund I, L.P. (the “Fund”) became the ...
WebApr 14, 2024 · Prometheus Biosciences Inc (RXDX) stock is trading at $112.60 as of 2:08 PM on Friday, Apr 14, a drop of -$0.26, or -0.23% from the previous closing price of … WebMar 18, 2024 · Prometheus Biosciences, Inc. (NASDAQ:RXDX - Get Rating) CEO Mark C. Mckenna sold 25,000 shares of the firm's stock in a transaction dated Wednesday, March 15th. The stock was sold at an average price of $116.14, for a total value of $2,903,500.00. Following the sale, the chief executive officer now directly owns 55,144 shares in the …
Web2 days ago · View Prometheus Biosciences, Inc RXDX investment & stock information. Get the latest Prometheus Biosciences, Inc RXDX detailed stock quotes, stock data, Real … WebThe Prometheus price today is $4.56 USD with a 24 hour trading volume of $1.01M USD. Prometheus (PROM) is down -0.85% in the last 24 hours. About. Prometeus Network is a …
WebPrometheus Biosciences Inc (RXDX) Stock Price Today, News, Quotes, FAQs and Fundamentals 1.47% Trending 3.84% 37.04% SWFTC.X 18.63% KAS.X 19.19% DESO.X 5.54% BOND.X 9.05% FORTH.X 23.75% BUD 0.06% CGDV 0.97% PH 0.14% 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here. RXDX Prometheus …
Web2 days ago · Prometheus Biosciences Inc is a biotechnology company pioneering a precision medicine approach to the discovery, development, and commercialization of … tori goiWebMar 8, 2024 · Prometheus Biosciences was founded in 2016 and booked $1 million in collaboration revenue for the 12 months ended December 31, 2024. It plans to list on the … tori g\u0027s catskillWebView the latest Prometheus Biosciences Inc. (RXDX) stock price, news, historical charts, analyst ratings and financial information from WSJ. tori gomez ageWeb2 days ago · Prometheus Biosciences (RXDX) Stock Price & Analysis 156 RXDX Stock Chart & Stats Advanced Chart > Day’s Range $0 - $0 52-Week Range $21.50 - $129.60 Previous Close $111.29 Volume 166.32K Average Volume (3M) 511.11K Market Cap $4.99B Enterprise Value $4.62B Total Cash (Recent Filing) $695.75M Total Debt (Recent Filing) … tori gomezWeb2 days ago · Prometheus Biosciences - RXDX - Stock Price Today - Zacks Prometheus Biosciences (RXDX) (Real Time Quote from BATS) $105.82 USD -0.65 (-0.61%) Updated Mar 23, 2024 10:12 AM ET Add to... tori global logoWebApr 12, 2024 · Prometheus Biosciences Stock Up 0.5 %. NASDAQ RXDX opened at $113.97 on Wednesday. The stock has a market cap of $5.42 billion, a PE ratio of -32.75 and a beta of -0.60. Prometheus Biosciences ... tori goproWebDec 8, 2024 · On December 7, 2024, Prometheus reported positive Phase 2 results for PRA023 and that it intended to proceed to Phase 3 trials. The stock rose from about $40 per share before that to a close of... tori google